Freedman, Benjamin S.
Brooks, Craig R.
Lam, Albert Q.
Fu, Hongxia
Morizane, Ryuji
Agrawal, Vishesh
Saad, Abdelaziz F.
Li, Michelle K.
Hughes, Michael R.
Werff, Ryan Vander
Peters, Derek T.
Lu, Junjie
Baccei, Anna
Siedlecki, Andrew M.
Valerius, M. Todd
Musunuru, Kiran
McNagny, Kelly M.
Steinman, Theodore I.
Zhou, Jing
Lerou, Paul H.
Bonventre, Joseph V.
Article History
Received: 28 May 2015
Accepted: 24 September 2015
First Online: 23 October 2015
Change Date: 4 March 2016
Change Type: Update
Change Details: This paper was updated shortly after publication following a technical error that resulted in a significant loss of image quality in Figure 7. Both the PDF and HTML versions of the figure have been corrected.
Competing interests
: J.V.B. holds patents on KIM-1 entitled ‘Kidney injury-related molecules’, patent number US6664385. The rights have been assigned to Partners Healthcare. The remaining authors declare no competing financial interests.